Overview

Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of IV Micafungin versus IV Fluconazole in the treatment of patients with Esophageal Candidiasis
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Echinocandins
Fluconazole
Micafungin